Humanized antibodies to amyloid beta comprising cdrs integrated into human- or primate-framework regions and constant regions with specific mutations

摘要

The present application is related to chimeric and humanized antibody and to methods and compositions for the therapeutic and diagnostic use in the treatment of amyloidosis, a group of disorders and abnormalities associated with amyloid protein such as Alzheimer's disease.